A Trial Comparing Mini-posterior Approach and Direct Anterior Approach
A Prospective, Randomized, Clinical Trial Comparing the Clinical Outcomes Following Total Hip Arthroplasty by a Single Surgeon Using Either a Mini-posterior Approach or a Direct Anterior Approach
1 other identifier
interventional
66
1 country
1
Brief Summary
The purpose is to determine if differences exist in the attainment of functional milestones that reflect activities of daily living between mini-posterior and direct anterior approach total hip arthroplasty (THA). The investigators also hope to determine if the general health outcome after direct anterior total hip arthroplasty was better than that after mini-posterior-incision total hip arthroplasty as measured with Short Form-12 (SF-12) scores, and to evaluate variation of surgical factors of the two procedures on the basis of the operative time, component positioning, and occurrence of early complications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2009
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2009
CompletedFirst Submitted
Initial submission to the registry
November 30, 2009
CompletedFirst Posted
Study publicly available on registry
December 2, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2013
CompletedResults Posted
Study results publicly available
October 30, 2014
CompletedOctober 30, 2014
October 1, 2014
3.8 years
November 30, 2009
December 31, 2013
October 28, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Days for Discontinue Assistive Devices
The primary early functional endpoint is the difference between groups in the postoperative days that patients require any assistive devices for ambulation. Lower number of days indicate better outcomes.
6 week
Secondary Outcomes (8)
Harris Hip Score
3 week
Western Ontario and McMaster Universities Arthritis Index (WOMAC)
3 week
Abduction Angle
6 wk
Anteversion Angle
6 week
Harris Hip Score
6 week
- +3 more secondary outcomes
Study Arms (2)
Mini-Posterior Approach
ACTIVE COMPARATORMini-Posterior surgical approach for total hip arthroplasty
Direct Anterior Approach
EXPERIMENTALDirect Anterior surgical approach for total hip arthroplasty
Interventions
Mini-Posterior surgical approach for total hip arthroplasty
Direct Anterior surgical approach for total hip arthroplasty
Eligibility Criteria
You may qualify if:
- The subject is willing and able to understand, sign and date the study specific Patient Informed Consent and Health Insurance Portability and Accountability Act (HIPPA) authorization to volunteer participation in the study.
- The subject is between 25 and 80 years of age at the time of surgery.
- The subject has elected to undergo primary total hip arthroplasty for osteoarthritis.
- The subject is psychosocially, mentally and physically able to comply with the requirements of the study including post-operative clinical, radiographic evaluations and completion of patient questionnaires.
- The subject is skeletally mature.
You may not qualify if:
- The subject has a BMI greater than 35.
- The subject has had a previous total hip arthroplasty.
- The subject has inflammatory arthritis.
- The subject has any type of infection.
- The subject has developmental dysplasia of the hip.
- The subject has a known metal allergy.
- The subject has an extreme offset of greater than 50 mm.
- The subject has an acetabular deformity requiring advanced reconstructive techniques.
- The subject has Charcot's disease.
- The subject has Paget's disease
- Dependence on narcotics for 6 months (or longer)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
OrthoCarolina, P.A.
Charlotte, North Carolina, 28207, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Susan Odum
- Organization
- OrthoCarolina Research Institute
Study Officials
- PRINCIPAL INVESTIGATOR
John Bohannon Mason, MD
OrthoCarolina, P.A.
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 30, 2009
First Posted
December 2, 2009
Study Start
November 1, 2009
Primary Completion
September 1, 2013
Study Completion
September 1, 2013
Last Updated
October 30, 2014
Results First Posted
October 30, 2014
Record last verified: 2014-10